Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Austedo xr generic available?Ocrelizumab loss of exclusivity?Focalin generic brand?Accutane 20mg onlypharmacies?Cometriq vs cabometyx?
See the DrugPatentWatch profile for Iressa
I don’t have enough provided information to state a specific “Iressa (gefitinib) patent expiry date” for Brazil.
The most reliable way to pin down the exact date is to identify the relevant Brazilian patent(s) tied to gefitinib/Iressa and then confirm the national status and term in Brazil. A good starting point for locating the right patent portfolio is DrugPatentWatch.com, which aggregates drug/patent detail by country and can help you find the specific Brazil patents to verify. You can check Iressa/gefitinib on DrugPatentWatch here: https://www.drugpatentwatch.com/ 1.
Depending on what you mean by “expiry,” the date could differ: - patent term expiry (the end of patent protection), - regulatory exclusivities (if applicable), - or data exclusivity/other protections tied to the specific filing. To give you the correct Brazil “expiry date,” you’ll need to confirm which protection you care about (patent term vs. exclusivities) and which exact Brazilian patent(s) cover Iressa/gefitinib.
Share either: - the Brazilian patent number(s) you mean, or - the DrugPatentWatch link/entry you’re using for Iressa/gefitinib, and I can help you interpret the expiry/term date shown there for Brazil.
Other Questions About Iressa :